Citations

Clear

561 citation(s) found for "Yu, Mei".

Alignment of large language models in solving medical ethical dilemmas
Sorin, Vera , Glicksberg, Benjamin S., Korfiatis, Panagiotis , Yeow, Mei-Ean, Brandeland, Megan, Nadkarni, Girish N., Klang, Eyal, Klang, Eyal , Collins, Jeremy D. , Glicksberg, Benjamin S. , Yeow, Mei-Ean , Brandeland, Megan , Nadkarni, Girish N.

Mayo Clinic

DIGITAL HEALTH | February 26, 2026 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/20552076261428395 | PMID 41767866 Get It

Background Large language models (LLMs) are entering clinical workflows, yet their alignment with medical-ethical principles is unclear. Objective To evaluate how LLMs reconcile deontological and utilitarian reasoning in medically adapted “Trolley dilemma” scenarios. Methods We tested 14 LLMs, including GPT-o1-preview and DeepSeek-R1-Distill-Llama, using five medically adapted Trolley dilemmas sourced from philosophical and real-world scenarios. Each model generated 10 independent answers per case (overall 700 responses). Responses were forced to “yes” (utilitarian) or “no” (deontological). The primary outcome was the proportion of utilitarian choices. χ 2 tests compared models. Results LLM responses varied. Some models, such as GPT-4 and Gemma, selected the utilitarian option in 20% of cases, while others, like Qwen-2-7B, reached 80% ( p < .001). GPT-o1-preview and DeepSeek-R1-Distill-Llama selected utilitarian responses in 44% and 38% of cases, respectively. Some models selected the consequence-maximizing option in vignettes where doing so required overriding consent or endorsing intentional harm within the scenario framing. Seven of the fourteen models tested recommended impermissible medical actions, including nonconsensual limb amputation, killing a healthy person for organ harvesting, and transferring a patient to hospice against their wishes, in 44 of 700 outputs (6.3 %). Conclusions In this constrained forced-choice stress test, models occasionally endorsed boundary-violating actions within the vignette framing. These results do not generalize to routine clinical decision-making, but motivate further benchmarked evaluation of refusal behavior and boundary constraints in ethically sensitive medical contexts. We must carefully define how these models influence clinical decisions, establish robust ethical guidelines for their use, and ensure that fundamental ethical norms are not compromised.
When Anatomy Meets Hemodynamics: Interpreting CTA Planimetry of Aortic Valve Area
Nkomo, Vuyisile T., Tsai, Chieh-Mei , Nkomo, Vuyisile T. , Nkomo, Vuyisile T

Mayo Clinic

Circulation: Cardiovascular Imaging | February 17, 2026 | Volume: 19 | Issue: 3 | Pages: No page available

10.1161/circimaging.126.019572 | PMID 41700396 Get It

Role of prefrontal cortex in freezing of gait in Parkinson’s disease: mechanisms and neuroimaging evidence
Ji, Qiling , Mei, Shanshan, Cai, Lipeng, Elmadhoun, Omar, Ding, Yuchuan, Geng, Xiaokun, Cai, Lipeng, Ding, Yuchuan , Geng, Xiaokun

Mayo Clinic

Frontiers in Neurology | February 17, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fneur.2026.1713795 | PMID 41783853 Get It

Freezing of gait (FOG) is a complex and highly disabling motor symptom that frequently affects patients with Parkinson’s disease (PD), especially in the middle and late stages. Although traditionally associated with motor deficits, accumulating evidence suggests that FOG is also strongly influenced by non-motor domains, including cognitive dysfunction and emotional disturbances. The prefrontal cortex (PFC), a key hub for executive functions, attention, and emotional regulation, has been increasingly implicated in the pathophysiology of FOG. Structural and functional abnormalities in the PFC, particularly in the dorsolateral prefrontal cortex (DLPFC) and medial prefrontal cortex (MPFC), have been reported in PD patients with FOG. This narrative review aims to summarize current evidence on the role of the prefrontal cortex in the development and modulation of freezing episodes, focusing on neuroimaging findings. Clarifying the contribution of frontal lobe dysfunction to FOG may inform therapeutic strategies targeting frontostriatal circuits to improve mobility and quality of life in PD patients. This is a narrative review and does not employ formal systematic review methodology.
Using a participation monitoring database to enhance recruitment in a rare cancer population
O’Rorke, Michael A. , Gryzlak, Brian , Xu, Tao, DeCook, Rhonda, Rudzianski, Nicholas J., Serrano, Kimberly , Wehrheim, Abigayle M., Schnell, Michael J., Witter, Carrie L., Gamblin, T. Clark , Kazmi, Syed Sohail, Cowell, Lindsay G., Else, Tobias, Chandaka, Sravani , Sanoff, Hanna K. , He, Fiona , Ramirez, Robert A., Liu, Mei, Lancaster, William, Mailman, Josh , Moran, Heather, Wahmann, Maryann, Gellerman, Elyse, Chrischilles, Elizabeth A., Liu, Mei , Sanoff, Hanna , O’Rorke, Michael , McDowell, Bradley D. , Rudzianski, Nicholas J , Serrano, Kimberly C., Grewal, Udhayvir Singh , Chandrasekharan, Chandrikha , Dillon, Joseph S. , Hálfdánarson, Þorvarður R. , Cowell, PhD Lindsay G., Else, Tobias , Soares, Heloisa P. , Sukrithan, Vineeth , Geller, David A. , Ramirez, Robert A., Lancaster, William, Chrischilles, Elizabeth A.

Mayo Clinic

Journal of Clinical and Translational Science | February 13, 2026 | Volume: 10 | Issue: 1 | Pages: No page available

10.1017/cts.2026.10703 | PMID 41822553 Get It

Abstract Introduction: Recruitment for rare disease studies is challenging due to small eligible populations. Traditional clinical research management systems often lack tools to track recruitment contacts prior to enrollment. The NET-PRO study, focused on neuroendocrine tumors (NETs), implemented a participation monitoring system to enhance recruitment efficiency and representativeness. Methods: NET-PRO is a multicenter cohort study of 2538 adults diagnosed with gastroenteropancreatic (GEP) or lung NETs between January 2018 and September 2024. Recruitment occurred from January 2022 to February 2025 across 14 U.S. medical centers. Sites used flexible recruitment methods (email, mail, phone, in-clinic) and tracked contacts using REDCap-based tools. Participant characteristics were analyzed by enrollment mode (online or mail) and recruitment difficulty (number of contacts required prior to enrollment) using standardized mean differences, chi-square tests, and ANOVA. Results: Of 9279 contacted patients, 2675 consented (28.8%) and 2538 enrolled (27.4%). Most enrolled online (83.2%), while 16.8% enrolled by mail. Mail respondents were older, had lower education and income, and more comorbidities. Among those enrolled, recruitment difficulty was associated with older age, lower education and income, but not comorbidity. Over half of the most difficult-to-recruit participants enrolled online. Contact methods varied by attempt, with email dominating early contacts and phone/mail used more in later attempts. Conclusions: A participation monitoring tool supported flexible, multimodal recruitment and improved sample representativeness in a rare cancer study. Tracking recruitment contacts enabled adaptive strategies and may reduce bias in observational research by enabling better outreach to harder-to-reach populations.
High NKAP expression predicts poor prognosis of breast cancer patients
Li, Yonghao , Zheng, Shu , Sun, Chenyu, Lowe, Scott, Bentley, Rachel, Li, Yaru , King, Bethany, Chen, Shuya, Zhou, Qin, Zhang, Mei , Bentley, Rachel

Mayo Clinic

Medicine | February 6, 2026 | Volume: 105 | Issue: 6 | Pages: e47497

10.1097/md.0000000000047497 | PMID 41650063 Get It

NF-κB activating protein (NKAP) plays important roles in various cancers, including breast cancer. However, its expression and prognosis value in breast cancer remains uncertain. Gene expression profiling interactive analysis, Human protein atlas database, and University of Alabama at Birmingham Cancer data analysis portal database were used to predict the expression and prognostic value of NKAP in breast cancer. Immunohistochemistry, quantitative real time polymerase chain reaction (qRT-PCR) and western blot were performed to detect NKAP expression. The effects of NKAP on cell proliferation, migration and drug sensitivity were investigated in MDA-MB-231 and SK-BR-3 cells. NKAP protein expression differed in breast cancer tissues and paraneoplastic tissues based on the cancer genome atlas data. The high NKAP expression was significantly correlated with a poor prognosis in breast cancer patients. The results of immunohistochemistry, western blot assay, and qRT-PCR proved that NKAP was highly expressed in breast cancer tissues compared with paraneoplastic tissues. In addition, qRT-PCR results showed that high expression of NKAP was significantly correlated with the larger tumor size and higher TNM stage. Moreover, knockdown of NKAP significantly inhibited the proliferation, migration, and enhanced drug sensitivity of MDA-MB-231 and SK-BR-3 cells. NKAP is highly expressed in breast cancer tissues, and its high expression is closely associated with poor prognosis. NKAP also promotes proliferation, migration, and inhibits drug sensitivity of breast cancer cells.
Blocking RAN translation without altering repeat RNAs rescues C9ORF72 -related ALS and FTD phenotypes
Jiang, Xin , Schaeffer, Laure, Patni, Divya, Russo, Tommaso , Lee, Chao-Zong, Aguilar, Corey, Marques, Christine , Jansen-West, Karen, Hruška-Plocháň, Marián , Ray-Soni, Ananya, Lim, Su Min , Held, Aaron , Yue, Mei, Otero, Paula Castellanos, Aryal, Sandeep , Beaussant, Hortense D. A. M. , Basu, Himanish , Takakuwa, Hiro , Daughrity, Lillian M. , Ramesh, Nandini , Costa, Paulo J. da, Quadros, Ana Rita A. A., Nolan, Matthew , Reyes, Charles Jourdan , Wheeler, Hayden J., Moran, Laura C. , Griesman, Grant , Wymann, Benjamin , Trombetta, Bianca A. , Lopez-De-Silanes, Emma Sofia , Canori, Michael, Silva, Yasmim Vieira Souza Da, Eriani, Gilbert , Albers, Mark W. , Arnold, Steven E. , Song, Yuyu , Jain, Ankur, Chiu, I., Zhang, Yong-Jie, Gao, Fen‐Biao , Wainger, Brian J. , Polymenidou, Magdalini , Petrucelli, Leonard, Martin, Franck , Lagier-Tourenne, Clotilde, Lagier‐Tourenne, Clotilde , Jansen-West, Karen R , Castellanos Otero, Paula, Da Costa, Paulo , A A Quadros, Ana Rita , Eriani, Gilbert , Albers, Mark W , Arnold, Steven E , Song, Yuyu , Chiu, Isaac M , Zhang, Yong-Jie , Gao, Fen-Biao , Wainger, Brian J , Polymenidou, Magdalini , Petrucelli, Leonard , Martin, Franck , Lagier-Tourenne, Clotilde , Lee, Chao-Zong , Jansen‐West, Karen , Ray-Soni, Ananya, Krishnan, Gopinath , Jain, Ankur , Petrucelli, Leonard

Mayo Clinic

Science | February 5, 2026 | Volume: 391 | Issue: 6785 | Pages: No page available

10.1126/science.adv2600 | PMID 41643021 Get It

GGGGCC (G 4 C 2 ) repeat expansion in C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Toxicity is thought to result from the accumulation of either repeat RNAs and/or dipeptide repeat proteins (DPRs) translated from repeat-containing transcripts through repeat-associated non-AUG (RAN) translation. To disentangle RNA from DPR toxicity, we mutated a CUG codon predominantly used to initiate DPR translation from all three reading frames. This mutation disrupted DPR synthesis while preserving the expression of repeat-containing RNAs. Despite the accumulation of RNA foci, behavioral deficits and pathological abnormalities, including p-TDP-43 inclusions, STING activation, motor neuron loss, neuroinflammation, and increased plasma neurofilament concentration, were alleviated in C9ORF72 mice. Base editing of the CUG codon also improved molecular phenotypes and survival in patient induced pluripotent stem cell–derived neurons, which highlights the potential of therapeutically targeting DPR production rather than repeat RNAs.
Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy
Sowamber, Ramlogan , Mei, Alice J. , Kaur, Paramdeep, McLeod, Julianne, McKay, Emily , Lukey, Alex, Bakkum-Gamez, Jamie, Buza, Natalia, Cohen, Paul A., Farrell, Rhonda, Garcia, Christine, Gilks, Blake, Goode, Ellen, Howitt, Brooke, Hui, Pei, Köbel, Martin , Kushi, Lawrence, Kwon, Janice, Long-Roche, Kara C., Malpica, Anais, McAlpine, Jessica N., Miller, Dianne , Oliva, Esther, Paliga, Aleksandra, Parra-Herran, Carlos, Pearce, Celeste Leigh , Piek, Jurgen Martinus, Qiu, Haiyan, Rabban, Joseph T. , Rome, Robert, Steenbeek, Miranda, Stone, R., Talhouk, Aline , Tischer, Kristin M., Huntsman, David G., Howitt, Brooke E. , Cohen, Paul A. , Piek, Jurgen M.J. , Tischer, Kristin M. , Köbel, Martin , Cohen, Paul , Kaur, Paramdeep , Bakkum‐Gamez, Jamie N. , Buza, Natália , Devins, Kyle M. , Farrell, Rhonda , Garcia, Christine , Gilks, C. Blake , Goode, Ellen L. , Hodgson, Anjelica , Hui, Pei, Huvila, Jutta , Karnezis, Anthony N. , Keyhanian, Kianoosh , Kinloch, Mary A. , Kommoss, Felix , Kushi, Lawrence H. , Kwon, Janice S. , Malpica, Anais, McAlpine, Jessica N. , Oliva, Esther , Palicelli, Andrea , Parra‐Herran, Carlos , Perera, Sharnel , Steenbeek, Miranda, Tischer, Kristin M. , Trabert, Britton , Webb, Penelope M. , Zalcberg, John , Huntsman, David G. , Hanley, Gillian E.

Mayo Clinic

JAMA Network Open | February 2, 2026 | Volume: 9 | Issue: 2 | Pages: e2557267

10.1001/jamanetworkopen.2025.57267 | PMID 41627818 Get It

This cohort study evaluates the reduction in risk of high-grade serous carcinoma among women undergoing opportunistic bilateral salpingectomy in Canada.
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia
Shadman, Mazyar, Chanan‐Khan, Asher , Campbell, David , Xue, Mei, Massoudi, Marjan , Williams, Rhys, Yang, Keri, Tam, Constantine S., Tam, Constantine S. , Shadman, Mazyar , Shadman, Mazyar , Xue, Mei , Tam, Constantine S , Williams, Rhys

Mayo Clinic

Future Oncology | January 31, 2026 | Volume: 22 | Issue: 3 | Pages: 339-348

10.1080/14796694.2026.2615736 | PMID 41618895 Get It

Prognostic Value of Artificial Intelligence–Enabled Electrocardiography–Derived Diastolic Dysfunction Grading and Trajectory in Patients Undergoing Transcatheter Aortic Valve Replacement
Tsai, Chieh-Mei , Naser, Jwan A. , Tsaban, Gal, Lee, Eunjung , Wood, Julia, Luis, Allen S., Thaden, Jeremy J. , Kane, Garvan C., Pislaru, Sorin V. , Simard, Trevor J., Greason, Kevin L. , Eleid, Mackram F., Oh, Jae K., Kane, Garvan C. , Simard, Trevor , Tsaban, Gal , Luis, Sushil A , Simard, Trevor , Eleid, Mackram F , Nkomo, Vuyisile T , Oh, Jae K. , Sabbah, Michael S. , Naser, Jwan A , Tsaban, Gal , Eleid, Mackram F. , Nkomo, Vuyisile T. , Oh, Jae K.

Mayo Clinic

Journal of the American Heart Association | January 30, 2026 | Volume: 15 | Issue: 3 | Pages: No page available

10.1161/jaha.125.046558 | PMID 41614319 Get It

Background Artificial intelligence (AI)–enabled electrocardiography has emerged as a tool for detecting cardiac dysfunction. The prognostic relevance of AI‐enabled electrocardiography–derived diastolic dysfunction (DD) in patients undergoing transcatheter aortic valve replacement had not been assessed. Methods We analyzed 3197 patients undergoing transcatheter aortic valve replacement for severe aortic stenosis between 2010 and 2023 with baseline 12‐lead ECGs processed by a validated AI model to classify diastolic function (grades 0–3). Multivariable Cox models and nested model comparisons assessed associations with all‐cause mortality, including a prespecified analysis in patients with indeterminate echocardiographic grading. Trajectories were defined by change in AI‐enabled electrocardiography DD grade (<2 versus ≥2) from baseline to 30‐day or 1‐year follow‐up. Results At baseline, 21% had grade 3, 57% had grade 2, 8% had grade 1, and 14% had grade 0 AI‐enabled electrocardiography DD. Higher grades were associated with adverse cardiac remodeling and comorbidities. Over a median follow‐up of 3.4 years, grade 3 AI‐enabled electrocardiography DD independently predicted mortality (hazard ratio [HR], 1.80 [95% CI, 1.47–2.20]; P <0.001). AI‐enabled electrocardiography DD improved prognostic discrimination beyond clinical and echocardiographic measures (ΔHarrell concordance statistic, 0.016; Δ χ 2 =57; P <0.001). Among 1259 patients with indeterminate echocardiographic grading, AI‐enabled electrocardiography added prognostic value (ΔHarrell concordance statistic, 0.02; Δ χ 2 =13; P =0.006). Worsening or persistently high‐risk trajectories were associated with increased mortality (HRs, 1.45–1.80; all P <0.05). Conclusions AI‐enabled electrocardiography–derived DD independently predicts mortality after transcatheter aortic valve replacement, adds value beyond echocardiographic grading, and enables dynamic risk stratification through longitudinal tracking.
Prospective patient preference study for Bruton tyrosine kinase inhibitor (BTKi) treatment attributes and factors affecting patient shared decision-making in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in the United States (US)
Challagulla, Swetha, Pilon, Dominic , Meng, Yan, Xue, Mei, Chen, Zhuo, Wang, Yuxi, Yang, Keri, Xue, Mei , Ailawadhi, Sikander , Totev, Todor

Mayo Clinic

Expert Review of Hematology | January 13, 2026 | Volume: 19 | Issue: 3 | Pages: 321-331

10.1080/17474086.2026.2617270 | PMID 41528878 Get It